HGH 191AA Guide & Dosage Chart

What is HGH 191AA?

HGH 191AA is the research shorthand for recombinant human growth hormone — a lab-made copy of the growth hormone your pituitary gland naturally produces. Its formal name is somatropin. The "191AA" part just tells you the protein is built from exactly 191 amino acids, which matches the sequence of real human growth hormone perfectly. ^[4]

Scientists make it by inserting the human GH gene into bacteria or other cells, which then churn out the protein. The result is chemically identical to the hormone your body already makes. Because it is a research-use-only compound in many contexts, it is studied rather than prescribed outside licensed clinical settings.

How HGH 191AA Works

Think of growth hormone as a master "broadcast signal." Once it enters the bloodstream, it travels to the liver and other tissues and tells them to produce a second messenger called IGF-1 (insulin-like growth factor 1). IGF-1 is what actually tells bones to grow longer, muscles to build protein, and fat cells to release stored energy.

In people whose bodies do not make enough growth hormone — a condition called growth hormone deficiency (GHD) — replacing it with somatropin restores that broadcast signal. Children with GHD grow faster toward a normal height. Adults with GHD may see improvements in body composition and metabolism. ^[4]

What the Research Shows

Most clinical research on HGH 191AA uses it as the gold-standard active comparator — the benchmark that newer, longer-acting formulations have to beat or at least match. That role actually tells us a lot about how well it works.

In a landmark Phase 3 trial, prepubertal children with GHD were randomized to receive either once-daily somatropin or a newer once-weekly compound called somatrogon. After 12 months, children on daily somatropin grew at 9.78 cm per year. The once-weekly drug was statistically noninferior — meaning daily somatropin set a high bar that a newer drug had to reach just to be considered equivalent. Both groups had similar mild-to-moderate side-effect rates (around 79%). ^[2]

A separate Phase 3 trial — the heiGHt trial — compared once-weekly lonapegsomatropin (a prodrug that slowly releases somatropin) against daily somatropin over 52 weeks in 161 treatment-naïve children. Daily somatropin produced an annualized height velocity of 10.3 cm per year and increased height standard deviation scores by 0.96. ^[5] Again, somatropin served as the reliable reference point.

Research on somatropin and breastfeeding is also documented. Limited data show that when mothers receive somatropin, breastmilk concentrations of growth hormone do not rise noticeably — and breastfed infants of those mothers have not shown adverse effects. Small studies found milk output increased 19–36% after a 7-day course of somatropin. ^[4] The closely related compound somatrem is poorly absorbed orally and is therefore unlikely to affect a nursing infant through breastmilk. ^[1]

What HGH 191AA Is Being Studied For

• Pediatric growth hormone deficiency — helping children with GHD achieve closer-to-normal height and growth velocity ^{[2] [5]}
• Adult growth hormone deficiency — restoring body composition, bone density, and metabolic function in adults whose pituitary glands underperform ^[4]
• Benchmarking new formulations — acting as the gold-standard comparator in trials of once-weekly and other long-acting GH analogs ^{[2] [5]}
• Lactation research — exploring whether somatropin can support milk production in mothers with low supply ^[4]

How HGH 191AA Is Dosed in Research

Dosing in clinical studies varies widely by the condition being investigated, the patient's age, body weight, and individual response. For a full breakdown of the specific doses used in research protocols — including the pediatric GHD regimen and the adult GHD titration range — see the dosage chart on this page. You can also use the calculator to explore weight-based figures used in published trials. Always remember: these are research reference doses only. Any use in humans requires the oversight of a licensed medical professional.

Mixing and Storing HGH 191AA

HGH 191AA (somatropin) is a fragile protein. It comes as a freeze-dried (lyophilized) powder and must be reconstituted — mixed with a liquid — before use in research settings.

• Reconstitution liquid: Bacteriostatic water (water with a small amount of benzyl alcohol) is most commonly used in research vials to extend shelf life after mixing. Plain sterile saline is an alternative. Important note: one manufacturer recommends avoiding benzyl-alcohol diluent for lactating women and using preservative-free normal saline instead. ^[4]
• How to mix: Inject the diluent slowly down the side of the vial — never shoot it directly onto the powder. Swirl gently; never shake. Shaking can break the protein chains and destroy activity.
• Storage before mixing: Keep lyophilized vials refrigerated (2–8 °C / 36–46 °F). Do not freeze.
• Storage after mixing: Reconstituted solutions should be refrigerated and typically used within 14–28 days depending on the specific product and diluent used. Check the product documentation for your specific vial.
• Visual check: The solution should be clear and colorless. Discard it if it looks cloudy, has particles, or has changed color.

These are general research-handling guidelines. Always follow the documentation provided with the specific research-grade product you are working with.

Sources

1. Somatrem. — , 2006. PMID 30000557.
2. Efficacy and Safety of Weekly Somatrogon vs Daily Somatropin in Children With Growth Hormone Deficiency: A Phase 3 Study. — The Journal of clinical endocrinology and metabolism, 2022. PMID 35405011.
3. Lonapegsomatropin. — , 2006. PMID 34554672.
4. Somatropin. — , 2006. PMID 30000556.
5. Weekly Lonapegsomatropin in Treatment-Naïve Children With Growth Hormone Deficiency: The Phase 3 heiGHt Trial. — The Journal of clinical endocrinology and metabolism, 2021. PMID 34272849.
6. Somatrogon. — , 2006. PMID 40864839.